SUMER JACQUELYN L
SEC CIK 1844824 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | CLO | 130.6K | — | $235.6K | 15 | 2023-02-17 | 2026-06-30 |
Most active insiders at CGEM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 10% | $11.93M | — |
| 2 | Michaelson Jennifer | CSO | — | $1.62M |
| 3 | Nichols Weston | 10% | $1.39M | — |
| 4 | AHMED NADIM | Pres, CEO, Dir | — | $518.0K |
| 5 | Jones Jeffrey Alan | Chief Medical Off | — | $178.9K |
| 6 | SUMER JACQUELYN L | CLO | — | $136.7K |
| 7 | Fenton Mary Kay | CFO | — | $59.9K |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 17:00 | 2026-06-30 | CGEM | Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | CLO | A - Grant | $8.60 | +2,470 | 130.6K | +2% | +$21.2K | |
| 2026-02-25 | 2026-02-24 | CGEM | Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | CLO | S - Sale | $14.47 | -3,601 | 128.1K | -3% | -$52.1K | |
| 2026-02-23 | 2026-02-20 | CGEM | Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | CLO | S - Sale | $13.62 | -3,742 | 131.7K | -3% | -$51.0K | |
| 2025-12-19 | 2025-12-18 | CGEM | Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | CLO | S - Sale | $9.67 | -3,480 | 135.4K | -3% | -$33.7K | |
| 2025-02-27 | 2025-02-25 | CGEM | Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | CLO | S - Sale | $8.53 | -3,756 | 136.9K | -3% | -$32.0K | |
| D | 2025-02-21 | 2025-02-19 | CGEM | Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | CLO | A - Grant | $0.00 | +50.0K | 140.7K | +55% | $0 |
| 2024-12-20 | 2024-12-18 | CGEM | Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | CLO | S - Sale | $11.41 | -3,482 | 90.7K | -4% | -$39.7K | |
| D | 2024-02-23 | 2024-02-22 | CGEM | Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | CLO | A - Grant | $0.00 | +50.0K | 94.1K | +113% | $0 |
| 2023-12-22 | 2023-12-21 | CGEM | Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | CLO | S - Sale | $8.50 | -1,400 | 44.1K | -3% | -$11.9K | |
| 2023-12-20 | 2023-12-18 | CGEM | Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | CLO | S - Sale | $8.22 | -290 | 45.5K | -0.6% | -$2,384 | |
| 2023-06-21 | 2023-06-20 | CGEM | Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | CLO | S - Sale | $12.94 | -291 | 45.8K | -0.6% | -$3,766 | |
| 2023-05-19 | 2023-05-18 | CGEM | Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | CLO | S - Sale | $8.76 | -291 | 46.1K | -0.6% | -$2,549 | |
| 2023-04-20 | 2023-04-18 | CGEM | Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | CLO | S - Sale | $10.71 | -290 | 46.4K | -0.6% | -$3,106 | |
| 2023-03-27 | 2023-03-20 | CGEM | Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | CLO | S - Sale | $11.32 | -305 | 46.7K | -0.6% | -$3,453 | |
| D | 2023-02-21 | 2023-02-17 | CGEM | Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | CLO | A - Grant | $0.00 | +47.0K | 47.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations